These results reveal that TRIM4 can be a valuable biomarker for evaluating HCC prognosis and that the loss of the TRIM4 protein in HCC tissues consistently suggests a worse prognosis. This evidence concerns the gene TRIM4 and hepatocellular carcinoma.